A risk-benefit assessment of pharmacotherapy for anxiety disorders in children and adolescents.

Hawkridge, S M

A risk-benefit assessment of pharmacotherapy for anxiety disorders in children and adolescents. [electronic resource] - Drug safety Oct 1998 - 283-97 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

0114-5916

10.2165/00002018-199819040-00004 doi


Adolescent
Anti-Anxiety Agents--adverse effects
Anxiety Disorders--drug therapy
Child
Humans